Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
BRAFV600E mutational status assessment in cutaneous melanocytic neoplasms in a group of the Egyptian population
IHC staining homogeneity may be more accurate in predicting BRAF V600E mutational status.
»
02/03/23
Depletion of SOD2 enhances nasopharyngeal carcinoma cell radiosensitivity via ferroptosis induction modulated by DHODH inhibition
Inducing oxidative stress by SOD2 inhibition sensitized nasopharyngeal carcinoma cells to ionizing radiation.
»
02/03/23
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
Sunitinib suggest that it could potentially be repurposed for local chemotherapy of RB.
»
02/01/23
Environmental signals perceived by the brain abate pro-metastatic monocytes by dampening glucocorticoids receptor signaling
EE reduces late stages of metastatic progression in lungs and also involved in novel anti-tumor mechanism.
»
02/01/23
Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment
Both CIBERSORTx and FCM analysis showed that ER expression associated with reduced infiltration of macrophages and CD4+ T cells.
»
01/31/23
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial.
T2b, higher GS, and higher PSA associated with increased RR for cancer-related.
»
07/19/22
Adversary of DNA integrity: A long non-coding RNA stimulates driver oncogenic chromosomal rearrangement in human thyroid cells.
CASTL1 expression elevated in tumors with CCDC6-RET fusion.
»
11/01/22
Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study.
Pembrolizumab plus chemotherapy maintained OS and PFS benefit versus placebo plus chemotherapy.
»
02/03/23
DNA methylation of GITR, OX40, 4-1BB, CD27, and CD40 correlates with BAP1 aberrancy and prognosis in uveal melanoma.
BAP1 aberrancy associated with decreased CpG methylation levels.
»
02/03/23
NPY methylated ctDNA is a promising biomarker for treatment response monitoring in metastatic colorectal cancer.
Baseline methylated ctDNA confirmed as prognostic marker.
»
01/25/23
< Prev
Next >